ASKLEPIOS Course on Hepato-Bilio-Pancreatic Imaging Biomarkers

December 11-12, 2017; Valencia/Spain
This course aims to familiarise fourth and fifth year radiology residents and board-certified radiologists with cutting-edge clinical and quantitative imaging technology. The two-day course addresses the definition and development of imaging biomarkers in clinical practice, focusing on the multivariate and multiparametric analysis of liver tumours, diffuse liver diseases and bilio-pancreatic conditions. The course will cover the clinical needs, technical solutions and practical implementation aspects. Also, the main biases in validating and reporting imaging biomarkers will be covered. Moreover, the course will discuss the state of the art of imaging biomarkers in these abdominal organs and how should they be implemented in daily clinical practice. A unique group of European faculty members, well known for their experience in applying novel imaging biomarkers, will offer top quality didactic lectures followed by technical considerations and clinical impact discussions in small groups.

Learning objectives

  • to understand different imaging biomarkers as spatially and temporally resolved surrogate indicators, representing virtual biopsies in the different abdominal pathologies
  • to critically evaluate the imaging biomarkers information related to individual patients' biological situation, clinical problems and treatment effects
  • to assess the correlation, specificity and biases between surrogate imaging biomarkers and the different underlying processes

       Learning objectives by topic

Monday, December 11
12:45-13:00 Welcome and introduction
  General concepts
13:00-13:30    Concept and development of imaging biomarkers and radiomics
L. Marti-Bonmati, Valencia/ES
13:30-14:00 Measurement, accuracy, precision, confusion and validation
A. Alberich-Bayarri, Valencia/ES
Structure report in liver imaging and quantitation
L. Marti-Bonmati, Valencia/ES
14:30-15:00 Coffee break
  Liver: Quantitative oncology
15:00-15:30 HCC and tumour hallmarks
V. Vilgrain, Clichy/FR
15:30-16:00 Contrast Enhanced and perfusion metrics in oncology
R. Quelever, Clichy/FR
16:00-16:30 Metastases and tumour response
V. Vilgrain, Clichy/FR
16:30-18:00 Workshops
V. Vilgrain, R. Quelever
Closing remarks
Tuesday, December 12
  Liver: Quantitative diffuse deposits
08:30-09:00    Liver fat and inflammation
M. França Oliveira, Porto/PT
09:00-09:30 Quantitative diffuse liver biomarkers
A. Alberich-Bayarri, Valencia/ES
Liver iron
M. França Oliveira, Porto/PT
10:00-11:30 Workshops
M. França Oliveira, A. Alberich-Bayarri
  Clinical trials
Imaging biomarkers in drug toxicity
J. Waterton, Manchester/UK
12:00-13:00 Lunch break
  Biliar and pancreas: Quantitative oncology
13:00-13:30 Biliary tumours: prognosis tumour hallmarks and tumour response
C. Matos, Lisbon/PT
13:30-14:00 Diffusion metrics in oncology
N. Papanikolaou, Lisbon/PT
14:00-14:30 Neuroendocrine tumours: hallmarks and tumour response
C. Matos, Lisbon/PT
Coffee break
15:00-16:30 Workshops
C. Matos, N. Papanikolaou  
  Clinical trials
Imaging biomarkers in clinical trials and daily practice
J. Waterton, Manchester/UK
Closing remarks and certificate of attendance
Back to overview

About ESOR

... an established and growing institution, fulfilling the mission of the European Society of Radiology (ESR) in the field of education.

                     Anastas Doreski, Skopje/MK

            Enrique F. Garces-Inigo, Albacete/ES

         Bruno Hochhegger, Porto Alegre/BR

            Saulius Rutkauskas, Kaunas/LT
ESR Contact
  • ESR Office:
  • Neutorgasse 9
  • 1010 Vienna, Austria
  • Tel: +43-1-533 40 64
  • Fax: +43-1-533 40 64-447
The European School
of Radiology (ESOR)
is an initiative of the
European Society of